The patient was a heterozygote carrier for apolipoprotein-E <i>ε</i>4 that increases the risk of sporadic Cerebral Amyloid Angiopathy (CAA), which is characterized by beta-amyloid accumulation and fibrinoid necrosis in cerebral vasculature leading to micro/macrohemorrhages and dementia. Here, APOE is linked to dementia.